Clevenger CV - Search Results

1

Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.

Wu AM, Dalvi P, Lu X, Yang M, Riddick DS, Matthews J, Clevenger CV, Ross DD, Harper PA, Ito S. Wu AM, et al. Among authors: clevenger cv. Mol Pharmacol. 2013 Feb;83(2):377-88. doi: 10.1124/mol.112.082362. Epub 2012 Nov 13. Mol Pharmacol. 2013. PMID: 23150485

2

Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells.

Fang F, Zheng J, Galbaugh TL, Fiorillo AA, Hjort EE, Zeng X, Clevenger CV. Fang F, et al. Among authors: clevenger cv. J Mol Endocrinol. 2010 Jun;44(6):319-29. doi: 10.1677/JME-09-0140. Epub 2010 Mar 17. J Mol Endocrinol. 2010. PMID: 20237142 Free PMC article.

3

Negative cross talk between NFAT1 and Stat5 signaling in breast cancer.

Zheng J, Fang F, Zeng X, Medler TR, Fiorillo AA, Clevenger CV. Zheng J, et al. Among authors: clevenger cv. Mol Endocrinol. 2011 Dec;25(12):2054-64. doi: 10.1210/me.2011-1141. Epub 2011 Sep 29. Mol Endocrinol. 2011. PMID: 21964595 Free PMC article.

4

Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer.

Zheng J, Koblinski JE, Dutson LV, Feeney YB, Clevenger CV. Zheng J, et al. Among authors: clevenger cv. Cancer Res. 2008 Oct 1;68(19):7769-78. doi: 10.1158/0008-5472.CAN-08-0639. Cancer Res. 2008. PMID: 18829531

5

Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.

Fang F, Rycyzyn MA, Clevenger CV. Fang F, et al. Among authors: clevenger cv. Endocrinology. 2009 Apr;150(4):1597-606. doi: 10.1210/en.2008-1079. Epub 2008 Nov 26. Endocrinology. 2009. PMID: 19036881 Free PMC article.

6

Prolactin receptor-integrin cross-talk mediated by SIRPα in breast cancer cells.

Galbaugh T, Feeney YB, Clevenger CV. Galbaugh T, et al. Among authors: clevenger cv. Mol Cancer Res. 2010 Oct;8(10):1413-24. doi: 10.1158/1541-7786.MCR-10-0130. Epub 2010 Sep 8. Mol Cancer Res. 2010. PMID: 20826546 Free PMC article.

7

The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.

Fiorillo AA, Medler TR, Feeney YB, Wetz SM, Tommerdahl KL, Clevenger CV. Fiorillo AA, et al. Among authors: clevenger cv. Am J Pathol. 2013 Jan;182(1):217-33. doi: 10.1016/j.ajpath.2012.09.021. Epub 2012 Nov 14. Am J Pathol. 2013. PMID: 23159947 Free PMC article.

8

HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.

Medler TR, Craig JM, Fiorillo AA, Feeney YB, Harrell JC, Clevenger CV. Medler TR, et al. Among authors: clevenger cv. Mol Cancer Res. 2016 Oct;14(10):994-1008. doi: 10.1158/1541-7786.MCR-16-0109. Epub 2016 Jun 29. Mol Cancer Res. 2016. PMID: 27358110 Free PMC article.

9

Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells.

Schauwecker SM, Kim JJ, Licht JD, Clevenger CV. Schauwecker SM, et al. Among authors: clevenger cv. J Biol Chem. 2017 Feb 10;292(6):2237-2254. doi: 10.1074/jbc.M116.764233. Epub 2016 Dec 29. J Biol Chem. 2017. PMID: 28035005 Free PMC article.

10

Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.

Craig JM, Turner TH, Harrell JC, Clevenger CV. Craig JM, et al. Among authors: clevenger cv. Endocrinology. 2021 May 1;162(5):bqab036. doi: 10.1210/endocr/bqab036. Endocrinology. 2021. PMID: 33589921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters